AxioMed Spine has completed the first part of its third financing round, raising $6.4 million from ”leading venture capital firms,” which were not named.
The company that is developing next-generation spinal disc replacements is working toward a Series C round of $18.5 million, according to a written statement by its president and CEO, Patrick McBrayer.
MedCityNews... http://ow.ly/I1oY...
